MD Anderson Cancer Center
|
|
- Stephanie Hollie Thompson
- 8 years ago
- Views:
Transcription
1 MD Anderson Cancer Center A Global Perspective to Eliminate Cancer Hilario E. Mata, PhD, MBA Director, Global Academic Programs
2 The mission of The University of Texas M. D. Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention and through education for undergraduate and graduate students, trainees, professionals, employees and the public.
3 We shall be the premier cancer center in the world, based on the excellence of our people, our researchdriven patient care and our science. We are Making Cancer History #1 Cancer Center in the U.S.A. Ranked No. 1 U.S. cancer hospital for 10 out of 12 years
4 The Texas Medical Center
5 MD Anderson Campuses at the Texas Medical Center North Campus Cores Sequencing and Microarray Research Animal Support* Genetically Engineered Mouse Facility* Small Animal Imaging* Tissue Biospecimen and Pathology Resource* Flow Cytometry* Patient-Reported Outcomes Biostatistics Bioinformatics Clinical Trials Support Clinical and Translational Research Center shrna and ORFeome ehealth 15.3 millions gross square feet in operation South Campus Cores Chemistry Research Animal Support* Genetically Engineered Mouse Facility* Small Animal Imaging* Tissue Biospecimen and Pathology Resource* Characterized Cell Line Core Electron Microscopy Flow Cytometry* Monoclonal Antibody Reverse Phase Protein Array TALENs
6 North Campus Facilities Mitchell Basic Science Research Building Clark Clinic Cancer Prevention Building Alkek Hospital & Lutheran Pavilion Mays Clinic LeMaistre Clinic Pickens Academic Tower
7 North Campus Aerial View
8 South Campus Facilities Research Building 3 Research Building 1 Research Building 2 Research Building 3 Smith Research Building
9 MD Anderson Strengths Largest freestanding cancer center in the world - nearly 30,000 employees, faculty, trainees, & volunteers Delivers the highest standard of cancer treatment and care - unprecedented breadth and depth of clinical oncology data and knowledge Tremendous expertise due to the large numbers of cancer patients treated in care centers - 120,000 a year, 1/3 rd new patients Performs the greatest number of cancer clinical trials in the world each investigating new therapies >1,000 trials Receives the highest level of peer-reviewed National Cancer Institute funding among all US universities - $182M in federal grants/year An extensive track record of research milestones and setting standards of care for cancer
10 Resources TOTAL OPERATING REVENUE FY2013 = $4,135,238,891 $3,178.9 Net patient revenue 76.9% $505.1 Restricted grants/contracts, philanthropy 12.2% $154.6 State-appropriated general revenue 3.7% $40.7 Auxiliary income 1.0% $75.6 Other income 1.8% $180.4 Investment and other non-operating income 4.4%
11 Research Expenditures FY2013 External Funding Federal Grants & Contracts $182,970,502 Private Industry Grants & Contracts $65,579,036 Philanthropy & Foundation $101,642,898 Total $350,192,436 State & Internal Funding State-Appropriated General Revenue $11,776,785 Tobacco Settlement Receipts/LEER Funds $5,837,249 CPRIT $24,262,525 Hospital Operating Margins $182,770,342 Institutional Grants $95,730,271 Total $320,377,172 Total Research Expenditures $670,569,608
12 Clinical Divisions Radiation Oncology Pathology and Laboratory Medicine Cancer Medicine Pediatrics Cancer Prevention and Population Sciences Quantitative Sciences Internal Medicine Surgery Anesthesiology and Critical Care Diagnostic Imaging Pharmacy Nursing
13 Multidisciplinary Care Centers Designed to treat specific types of cancer by disease-site that has become MD Anderson s trademark Built on team approach that bring together surgeons, medical oncologists and radiation oncologists The Method: Research driven patient care, evidence based, performed in a multi-disciplinary setting
14 Multidisciplinary Care Centers Brain and Spine Breast Cancer Prevention Endocrine Gastrointestinal Genitourinary Head and Neck Gynecologic Leukemia Lymphoma and Myeloma Melanoma and Skin Pediatrics Sarcoma Stem Cell Transplant Thoracic
15 Ambulatory Care Building
16 Specialty and Treatment Centers Cancer Prevention Cardiopulmonary Integrative Medicine Internal Medicine Dermatology Orthopedic Pain Management Proton Treatment Radiation Treatment Reconstructive Surgery Supportive Care Stem Cell Transplant and Cellular Therapy
17 Proton Therapy Center
18 Survivorship Clinics Breast Childhood Cancers Colorectal Genitourinary Gynecologic Head and Neck Lymphomas Melanomas Stem Cell Transplants Thyroid Nutrition, psychosocial, energy balance, side effects, follow-up medical care, networking with other survivors
19 Cancer Prevention Building
20 Basic Science Departments Biochemistry and Molecular Biology Cancer Biology Genetics Molecular Carcinogenesis Immunology Molecular and Cellular Oncology Veterinary Medicine and Surgery Veterinary Sciences
21 Basic Science Research Building
22 Institutes Institute for Applied Cancer Science Institute for Personalized Cancer Therapy Institute for Basic Sciences Centers: Biological Pathways, Bio-molecular Structure and Function, Cancer Epigenetics, Environmental and Molecular Carcinogenesis, Genetics and Genomics, Inflammation and Cancer, Stem Cell and Developmental Biology Duncan Family Institute for Cancer Prevention and Risk Assessment Center for Translational and Public Health Genomics Institute for Cancer Care Excellence McCombs Institute for Early Detection and Treatment Centers: Advanced Biomedical Imaging Research, Cancer Immunology, Molecular Markers, Metastasis, Proton Therapy, RNA Interference and Non-Coding RNA, Targeted Therapy
23 Institute for Personalized Cancer Therapy (IPCT) MD Anderson will be the leader in implementing Personalized Cancer Therapy, based on an analysis of each patient s cancer that will integrate information across DNA, RNA, proteins and metabolomics in the context of the tumor in its microenvironment, the patient s immune system and the patient s own genotype.
24 Patients Accrued (1000 s) Patients Accrued (1000 s) Clinical Research Activity Interventional Protocols Non-interventional Protocols Industry Institutional Ext Peer National ,305 27,422 29,351 26, Fiscal Year Fiscal Year o Institutional protocols accounted for >50% of interventional enrollment o Of 399 industry-sponsored interventional protocols in FY2012, 130 (33%) were authored by or significantly influenced by MD Anderson investigators o Non-interventional protocol accruals include bio-specimen collection, ancillary and correlative studies and observational cohorts
25 Specialized Programs of Research Excellence (SPORE) Robert Bast P50 CA Ovarian Cancer Colin Dinney P50 CA Genitourinary Bladder Cancer Elizabeth Grimm P50 CA Melanoma Gabriel Hortobagyi P50 CA Breast Cancer Jean-Pierre Issa P50 CA Leukemia Scott Lippman P50 CA Head and Neck Cancer Chris Logothetis P50 CA Prostate Cancer Karen Lu P50 CA Uterine/Endometrial Cancers Robert Otlowski P50 CA Myeloma Jack Roth P50 CA Lung Cancer Anas Younes P50 CA Lymphoma Alfred Yung P50 CA rain Cancer
26 Recent Notable Publications RISK Hepatocellular Carcinoma Risk Prediction Model for the General Population: The Predictive Power of Transaminases Chi-pang Wen Xifeng Wu, J Natl Cancer Inst 104: , 2012 BASIC SCIENCE ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect Weiwei Yang Zhimin Lu, Nat Cell Biol 14: , 2012 TRANSLATIONAL Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma Lawrence N Kwong Lynda Chin, Nat Med 18: , 2012 CLINICAL Ponatinib in Refractory Philadelphia Chromosome Positive Leukemias Jorge E. Cortes et al, N Engl J Med 367: , 2012 SURVIVORSHIP Identification of the molecular basis of doxorubicin-induced cardiotoxicity Sui Zhang Edward T H Yeh, Nat Med 18: , 2012
27 Moonshot Program An strategic initiative to apply current knowledge & technology in order to accelerate declines in mortality for several major cancer types within the next 5-10 years. The selected inaugural programs were: Acute myeloid leukemia / Myelodysplastic syndrome Chronic lymphocytic leukemia Melanoma Lung cancer Prostate cancer Triple-negative breast cancer
28 MD Anderson Global MDACC Sister Institutions Co-Branded Institutions
29 MD Anderson Madrid - Spain Opened October 15, 2000
30 Banner MD Anderson Cancer Center Phoenix Opened September 26, appointments Scheduled through 1/31/ Initial Consults 684 Infusions 997 Follow-up appointments 916 Radiation treatments
31 GAP Rationale 1. MD Anderson has the determination, values and tools to play a leading role in eliminating cancer on a global scale 2. We are expanding the reach of our mission by building relationships with premier academic, health care and government that share our vision and can help enhance the international dimension to our academic programs 3. As a leading academic cancer center, it is our obligation to share our best practices and exchange research and training with premier cancer programs throughout the world 4. Many key research and epidemiologic questions in cancer can only be answered with international collaborations
32 GAP Objectives 1. Expand the availability and improve the quality of cancer care worldwide by sharing guidelines and pathways while also providing advice on case management. 2. Broaden the portfolio of basic, clinical and translational research, which has the potential for advancing diagnostic and therapeutic services that can provide worldwide benefits. 3. Build significantly on the global talent base of clinicians and researchers in the field of oncology.
33 The Sister Institution Network The GAP team oversees MD Anderson's Sister Institution relationships and the broader GAP network including institutions linked to us via memoranda of understanding. It is the largest such network dedicated to the fight against cancer in the world, including relationships with over 30 leading regional cancer fighting institutions in 21 countries throughout North and South America, Asia, Europe, Australia and Africa.
34 Sister Institution Network Worldwide
35 Sister Institutions Affiliations Australia 1. Peter MacCallum Cancer Centre, Melbourne Brazil 2. Hospital Israelita Albert Einstein, Sao Paulo 3. Hospital Do Cancer, A. C. Camargo, Sao Paulo 4. Hospital Do Cancer de Barretos Chile 5. Clinica Alemana, Santiago Colombia 6. Instituto de Cancerología Las Américas, Medellín
36 Sister Institutions Affiliations (cont.) China 7. Fudan University Cancer Hospital, Shanghai 8. Peking Union Medical College Cancer Institute, Beijing 9. Sun Yat-Sen University Cancer Center, Guangzhou 10. Tianjin Medical University Cancer Institute, Tianjin 11. Chinese University of Hong Kong, Hong Kong France 12. Institut Gustave Roussy, Villejuif Germany 13. German Cancer Research Center, Heidelberg
37 Sister Institutions Affiliations (cont.) India 14. All India Institute of Medical Science, Delhi 15. Tata Memorial Center, Mumbai Israel 16. Sheba Medical Center, Tel Aviv Japan 17. Kyoto University Graduate School of Med., Kyoto 18. Tokyo Oncology Consortium, Tokyo Jordan 19. King Hussein Cancer Center, Amman
38 Sister Institutions Affiliations (cont.) Korea 20. Yonsei University Medical Center, Seoul Lebanon 21. The American University of Beirut, Beirut Mexico 22. National Cancer Institute, Mexico City Norway 23. Norwegian Cancer Consortium Stavanger University Hospital, Stavanger Norwegian Radium Hospital, Oslo Cancer Registry of Norway, Oslo
39 Sister Institutions Affiliations (cont.) Poland Polish Cancer Consortium Sweden Karolinska Institute, Stockholm Turkey Hacettepe University Institute of Oncology, Ankara Taiwan China Medical University Hospital, Taichung United Kingdom Imperial College of London, London
40 Signing Ceremony
41 Academic Activities Basic, translational and clinical research collaborations Education exchanges: fellowships, training, observerships, MD/PhD programs, etc. Scientific symposia Medical education by Internet, videoconferencing or satellite broadcasting
42 Symposia
43 Videoconferences
44 Research Collaborations Tissue and tumor banking Immunology Gene therapy Bronchial airway research Microarray research and technology Traditional Chinese medicine Endocrinology Radiation and surgical oncology Leukemia, breast, thoracic, genitourinary, hepatobiliary colorectal, gastric and head & neck cancers
45 Sister Institution Network Fund (SINF) Funding mechanism to continue enhancing collaborations in research and education within the Sister Institution Network Eligibility: only projects developed in collaboration between faculty/staff at MD Anderson and one or more collaborating institutions are considered for funding Funding: up to $100,000 over one or two years for MD Anderson investigators. Funding levels and mechanisms for investigators at collaborating institutions to be determined by their home institution.
46 SINF - up to date 61 projects 3 RFAs (FY11/12/13) 36 collaborating institutions 23 countries MD Anderson: $6.1M Network: $6.4M Total: $12.5M Collaborate Globally & Fund locally Clinical Basic 10+ cancer types broad range of research First Papers Coming Out Nature (2); NEJM; Cell; Mol Cell; Nat Cell Biol; JBC (2) First Grants NCI (4); CPRIT (2); foundation
47 GAP Activities Research (publications) Collaborative publications co-authored with Sister Institution Faculty SINF started Many of the top institutions we co-author with are part of the Sister Institution Network DKFZ (German Cancer Research Center) is affiliated with University of Heidelberg GAP started Data obtained from SciVal Experts -
48 GAP Activities: Research (clinical trials) In 2011 gathered an inventory of the capabilities of 17 of our Sister Institutions regarding clinical trials shared this internally with clinical investigators Instituto De Cancerologia, Clinica Las Americas, Medellin, Colombia: *Conservative surgery for women with low-risk, early cervical cancer *Laparoscopic approach to cervical carcinoma: a phase III randomized clinical trial of laparoscopic or robotic radical hysterectomy versus abdominal radical hysterectomy in patients with early stage cervical cancer Fudan University Cancer Center, Shanghai, China: External qigong therapy for women with breast cancer prior to surgery Pilot study of Huachansu in patients with hepatocellular carcinoma, small cell lung cancer or pancreatic cancer (Phase I) *Huachansu and gemcitabine in pancreatic cancer (Phase II) Sheba Medical Center, Tel Hashomer, Israel & University of Heidelberg, Germany: A phase I, open-label, dose escalation study to evaluate the safety, tolerability and pharmacokinetics of INNO-406 in adult patients with Imatinib-resistant or intolerant Ph+ leukemias Institute Gustave Roussy, Paris, France: A phase II trial of the multitargeted kinase inhibitor E7080 in advanced radioiodine (RAI) refractory differentiated thyroid cancer (DTC)
49 SciVal Experts Track your own pu A directory of research expertise to find collaboration within your institution and the Sister Institution network Track publications and identify experts and publications Increasing visibility across the research community Identify potential collaborators and discover new relationships Find funding opportunities and connect authors to sponsors
50 Annual GAP Conference Provides a forum for faculty from MD Anderson and our Sister Institutions to develop collaborations and exchange research results and ideas Sessions are formed around topics of interest to the members of the SI Network The event is held at MD Anderson in odd years and is hosted by a Sister Institution in even years GAP 2014 Conference, Seoul, Korea May 1 3, 2014
51 Annual GAP Conference
52 GAP Strategy Expand the Sister Institution network by creating regional clusters with similar missions, economic, social and cultural backgrounds. Develop programs in line with MD Anderson s vision, driven by faculty interest and commitment that benefit all participants Encourage and support multi-institutional collaborations, primarily in clinical research to generate high-impact breakthroughs which impact cancer care worldwide
53 The Worldwide Innovative Networking (WIN) Consortium WIN Consortium in personalized cancer medicine was created in 2010 by MD Anderson and IGR to accelerate pace and reduce costs of translating novel cancer treatments through worldwide clinical trials and research projects Goal: to make an impact on personalized cancer therapy by increasing the number of patients having access to innovative, global clinical trials in the area of genomic-based cancer therapeutics Aims: to initiate research projects each year in a global consortium guided by an independent scientific advisory board
54 SI Iberoamerican Summit Nov Galvanize on the potential of the SI Network by recognizing commonalities and identifying opportunities: Clinical and translational research 1. Conservative Surgery for Women with Low-Risk, Early Stage, Cervical Cancer 2. A Phase III Randomized Trial of Laparoscopic or Robotic Radical Hysterectomy vs. Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer Cervical cancer is much prevalent in Colombia Outstanding contribution by IDC - to date, they remain the center with the highest and fastest accrual in both studies Prevention / Training & education 3. Integrative Epidemiology Global Training Program
55 Integrative Epidemiology Global Training Program Preeminent, and sustained training in contemporary & translational epidemiologic approaches across the lifespan of cancer care continuum, including: Integrative Epidemiology Integrative Prediction Model Cancer Registry & Population Sciences Biomarker Discovery Computational Epidemiology & omics Integrative Risk Models
56 Global Prevention Initiatives Nov. 27, 2012 LOI signed by the Commission of National Institutes and High Specialty Hospitals of Mexico, the National Cancer Institute of Mexico and MD Anderson Cancer Center Oct. 15, 2013 LOI signed by the Government of the City of Medellin, the Instituto de Cancerologia Clinica las Americas and MD Anderson Cancer Center, for: The development of community-based tobacco use prevention and control pilot programs for children and adolescents The development of formalized prevention and control programs, including programs related to public health policy, education for the public and professionals, clinical and community services, comprehensive initiatives, research endeavors; and other public health and academic programs The implementation, evaluation, refinement and dissemination of prevention and control programs.
57 Mexico Texas Tobacco Control Initiative
58 Thank You
THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
More informationFoundations of Oncology Nursing Practice
Foundations of Oncology Nursing Practice Course Syllabus Course Lead:, RN, MN, BScN, CON(C) Associate Faculty:, RN, CON(C) Last updated January 27, 2011 Course Description: This online course will introduce
More informationNCI Community Cancer Centers Program Program Overview Ascension Health St. Vincent Indianapolis Hospital
A. Name and location of hospital:, Indianapolis, IN B. Name of cancer center: St. Vincent Oncology Center C. Identify PI and key personnel with contact information for each pilot focus areas: a. Disparities
More informationFuture Directions in Cancer Research What does is mean for medical physicists and AAPM?
Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman
More informationFuture Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center
Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.
More informationSpecific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also
More informationThe University of Texas Health Science Center at San Antonio Tobacco Funds Budget Fiscal Year Ending August 31, 2015
Permanent Health Funds for Higher Education (Fund 810) Permanent Health Funds will be assigned to schools to support health education, research programs, and infrastructure operations. Strategy F.1.2.,
More informationCancer Services for Adults and Children
UCSF HEALTH Cancer Services for Adults and Children Our world-class clinical and research programs are engaged in the urgent effort to cure cancers and, where cures currently elude us, transform cancer
More informationAcademic and Visa Administration - Trainee. 2012-2013 Annual Report
Annual Report Trainee and Alumni Affairs 2012-2013 Annual Report Summary of Trainee Metrics and Growth Patterns for 2012-2013 Page Table 1 Annual Educational Trainee Metric Report 1 Table 2 Five-Year Educational
More informationCancer Research Graduate Programs. The University of Texas MD Anderson Cancer Center
Cancer Research Graduate Programs The University of Texas MD Anderson Cancer Center Mission The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation
More informationKey Staff Members EXECUTIVE TEAM Nancy Price Mendenhall, MD Medical Director Stuart Klein, MHA Executive Director Zuofeng Li, DSc Physics Director
Key Staff Members EXECUTIVE TEAM Nancy Price Mendenhall, MD Medical Director A University of Florida College of Medicine faculty member since 1985, Dr. Mendenhall served as the chair of the Department
More informationMaster Online Study Program @dvanced Oncology. Study part time team up internationally!
Master Online Study Program @dvanced Oncology Study part time team up internationally! Ulm University is developing an innovative international postgraduate study program @dvanced Oncology addressing clinical
More informationQuick Facts. Who We Are. Mission. Vision. Core Values
Who We Are 2015 Quick Facts The University of Texas MD Anderson Cancer Center, located in Houston on the campus of the Texas Medical Center, is one of the world s largest and most respected centers devoted
More informationKentucky Lung Cancer Research Program. 2010 Strategic Plan Update
Kentucky Lung Cancer Research Program 2010 Strategic Plan Update Approved by the KLCR Program Governance Board August 12, 2009 KLCR Program Strategic Plan Table of Contents Introduction... 3 GOAL 1: Investigator-Initiated
More information2 Year (2013 15) CLL/SLL Research Initiative CLL/SLL Collaborative Grant
2 Year (2013 15) CLL/SLL Research Initiative CLL/SLL Collaborative Grant Guidelines & General Instructions for Application KEY DATES: Application Release Date: December 12, 2012 Application Deadline: February
More informationU.S. News Best Global Universities Rankings: An inside look at the latest results and methodology
U.S. News Best Global Universities Rankings: An inside look at the latest results and methodology Robert J. Morse, Chief Data Strategist U.S. News & World Report 6th International Conference on World-Class
More informationScientifically Minded. Medically Driven.
Scientifically Minded. Medically Driven. MEDICALLY DRIVEN. 01 SCIENTIFICALLY MINDED. At Worldwide Clinical Trials we strategically balance science, medicine, operations and commercial intelligence to achieve
More informationThe Brain and Spine CenTer
The Br ain and Spine Center Choosing the right treatment partner is important for patients facing tumors involving the brain, spine or skull base. The Brain and Spine Center at The University of Texas
More informationHow Can Institutions Foster OMICS Research While Protecting Patients?
IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice
More informationA Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
More informationFulfilling the Promise
Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,
More informationNational Framework for Excellence in
National Framework for Excellence in Lung Cancer Screening and Continuum of Care declaration of purpose Rights and Expectations THE RIGHTS OF THE PEOPLE Lung cancer kills more Americans than the next four
More informationFACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
More informationKINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY. Always Here When You Need Us
KINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY Always Here When You Need Us Kings County Hospital Center Cancer Care Program ANNUAL REPORT 2013: EXECUTIVE SUMMARY The Kings County Hospital Center Cancer
More informationFiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements PCRP AWARD MECHANISMS WITH EMPHASIS ON RESOURCES Clinical Consortium Award
More informationALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
More informationExperience of a Pediatric Oncology Clinical Research Center in Brazil. Antonio Sergio Petrilli, MD, PhD
Experience of a Pediatric Oncology Clinical Research Center in Brazil Antonio Sergio Petrilli, MD, PhD Children and adolescents Heterogeneous in many aspects 38% of Brazilian population (IBGE, 2000) 11,530
More informationClinical Departments in the Biological Sciences
University of Chicago 1 Clinical Departments in the Biological Sciences Faculty in the Division of the Biological Sciences participate in undergraduate and graduate medical education through the Pritzker
More informationLCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH
LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH FUNDING OPPORTUNITY DESCRIPTION 2016 REQUEST FOR APPLICATION (RFA) Lung Cancer Foundation of America (LCFA) and the International
More informationGenomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
More information2015 Global Online Fellowship In Head & Neck Surgery and Oncology
2015 Global Online Fellowship In Head & Neck Surgery and Oncology The Fellowship There are no current global standards of training, practice and level of care for patients with neoplasms of the Head and
More informationAchievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for
Achievements Report August 2015 CURING CANCER Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for cancer? Since cancer is complex and comes in many forms, its
More informationTABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
More informationProposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine
Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...
More informationUMDNJ New Jersey Medical School
UMDNJ New Jersey Medical School NJMS History: Founded in 1954 as the Seton Hall College of Medicine and Dentistry, New Jersey Medical School is the state s oldest medical school. 1956 First class of 80
More informationat a critical moment Physician Suggestion Line...
Radiation Oncology Exceptional care at a critical moment When your patients require radiation therapy, they deserve the very best care available to them. The Department of Radiation Oncology provides exceptional
More informationUmass Medical School China Program Brochure
China Program Office 2011 Umass Medical School China Program Brochure University of Massachusetts Medical School - Worcester 2010 Ranking among US Medical Schools: UMass ranked 56th in the Times of London's
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationThe Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.
The Center for Prostate Cancer Personalized Treatment. Clinical Excellence. The Center for Prostate Cancer Leaders in Prostate Cancer Treatment and Research The Center for Prostate Cancer at the North
More informationDevelopment of Advanced Healthcare Systems in Australia. Professor Stephen Smith Dean
Development of Advanced Healthcare Systems in Australia Professor Stephen Smith Dean 7 April 2014 Global Comparison (2012 Data) Australia Population (millions) 22.3 GDP (US$ billions) 1541.8 GDP per capita
More informationHow To Choose A Pediatric Oncologist
Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the
More informationFuture Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
More informationCancer treatment. TOP EUROPEAN CANCER EXPERTISE The path to recovery
Cancer treatment TOP EUROPEAN CANCER EXPERTISE The path to recovery 0% LAND OF HIGH QUALITY HEALTHCARE Located in Finland, a land of high quality healthcare, Helsinki University Hospital is regarded as
More informationPeking University Health Science Center Introduction
Peking University Health Science Center Introduction Content 1 2 3 4 General Information Medical Service Medical Education Medical Research 5 International Cooperation General Information A Brief History
More information2015 NCI Cancer Clinical Investigator Team Leadership Award (CCITLA) Recipients. Focus area: small cell lung cancer. Focus area: gynecologic cancers
2015 NCI Cancer Clinical Investigator Team Leadership Award (CCITLA) Recipients Leora Horn, M.D., M.Sc. David Hyman, M.D. Matthew Katz, M.D. Edward Kim, M.D., Ph.D. Frederick Lansigan, M.D. Charles Leath,
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationStrategic Plan. Ambulatory Care 2013-2016. Exemplary Patient-Centred Ambulatory Care Experiences
Ambulatory Care Strategic Plan 2013-2016 Exemplary Patient-Centred Ambulatory Care Experiences Table of Contents 1.0 Executive Summary 3 2.0 Background and Context 4 3.0 The Ambulatory Care Model at Princess
More informationHACETTEPE UNIVERSITY
08.04.2015 16 135 OF 2015 The decree of Institute Committee dated 17.02.2015 and with number 1-02 of 2015 and the decree of University Education Commission about as of 2015-2016 Academic Year Fall Term,
More informationResumen Curricular de los Profesores. Jesse Boehm
Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub
More informationThe. for DUKE MEDICINE. Duke University School of Medicine. People
The for DUKE MEDICINE Decades of hard work by dedicated physicians and scientists, along with capable and often inspired leadership, have placed the Duke School of Medicine among the nation s best. Now,
More informationThe National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
More informationINSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific
More informationThe Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant
The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant Speech by Dr. Tsuneo A. Takahashi Translated by Stella Wang Japan and the United States are the two most experienced countries
More informationNational Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s National Cancer Institute
More informationCancer Research Experience Program. Opportunities for Howard University Students. 2016 Program Year
R O S W E L L PA R K C A N C E R I N S T I T U T E S Cancer Research Experience Program Opportunities for Howard University Students 2016 Program Year THE ROSWELL PARK/HOWARD UNIVERSITY CANCER SCHOLARS
More informationHouston Cancer Institute
Houston Cancer Institute A personal path to healing Memorial-West Houston Katy Northwest Houston Southeast Houston Sugar Land Convenience for Patients State of the Art Therapies and Diagnosis Real Support
More informationMeet Your Sparrow Cancer Center Team
Meet Your Sparrow Cancer Center Team Our integrated, multidisciplinary approach means every Patient is evaluated and cared for by a team managing all aspects of care from tests and treatments, to infusions,
More informationGlobal Real Estate Outlook
Global Real Estate Outlook August 2014 The Hierarchy of Economic Performance, 2014-2015 China Indonesia India Poland South Korea Turkey Australia Mexico United Kingdom Sweden United States Canada South
More informationImmuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
More informationSupport Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:
More informationDepartment of Anesthesia & Perioperative Medicine 5-Year Strategic Plan FY 2012-2016. Contents
Anesthesia & Perioperative Medicine 167 Ashley Avenue, Suite 301 MSC 912 Charleston, SC 29425-9120 Tel 843 792 2322 Fax 843 792 9314 Department of Anesthesia & Perioperative Medicine 5-Year Strategic Plan
More informationA BRIEF DESCRIPTON OF THE MEDICAL SCHOOL CURRICULA IN BRAZIL
A BRIEF DESCRIPTON OF THE MEDICAL SCHOOL CURRICULA IN BRAZIL 1. The Brazilian Educational System Primary and secondary schooling in Brazil and the United States are similar in terms of student age and
More informationWorld Class Personalized Cancer Medicine
World Class Personalized Cancer Medicine The Princess Margaret Cancer Centre Strategy 2013 2018 2015 Edition Contents 4 The Princess Margaret Cancer Centre 6 Accountability 7 Our Core Activities and Resources
More informationIf you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
More informationATHORACIC CENTER OF EXCELLENCE
THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS ATHORACIC CENTER OF EXCELLENCE PRECISION MEDICINE FOR LUNG CANCER, ESOPHAGEAL CANCER, AND MESOTHELIOMA A CANCER CENTER does not earn a reputation
More informationThe Science behind Proton Beam Therapy
The Science behind Proton Beam Therapy Anthony Zietman MD Shipley Professor of Radiation Oncology Massachusetts General Hospital Harvard Medical School Principles underlying Radiotherapy Radiation related
More informationInvestigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008
Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008 David R. Risser, M.P.H., Ph.D. David.Risser@dshs.state.tx.us Epidemiologist Cancer Epidemiology and Surveillance Branch
More informationThere must be an appropriate administrative structure for each residency program.
Specific Standards of Accreditation for Residency Programs in Radiation Oncology 2015 VERSION 3.0 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationAsk Us About Clinical Trials
Ask Us About Clinical Trials Clinical Trials and You. Our specialists and researchers are at the forefront of their fields and are leading the way in developing new therapies and procedures for diagnosing
More informationHow To Know If You Have Cancer At Mercy Regional Medical Center
MERCY REGIONAL CANCER CENTER 2012 CANCER PROGRAM ANNUAL REPORT Using 2011 Data Mercy Regional Cancer Center When you have cancer, you might think first of treatments chemotherapy and radiation. You want
More informationScientific Plan and Structure Established for NRG Oncology
Scientific Plan and Structure Established for NRG Oncology Dateline Saturday, January 26, 2013 With the submission of the NRG Oncology grant proposal to the National Cancer Institute (NCI) on January 15,
More informationCANCER CENTER SERVICES GUIDE
CANCER CENTER SERVICES GUIDE A Place of Hope and Healing Since 1999, The Robert and Carol Weissman Cancer Center at Martin Health has combined medical expertise with advanced technology and access to clinical
More informationNuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
More informationHow To Promote Healthcare Management
Welcome! Global Healthcare Management Consortium Under the auspice of With the leadership and support of The science of medicine is thousands of years old. The discipline of management sciences which includes
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More informationEducational Opportunities at Temple University. Deborah B. Nelson, Ph.D. dnelson@temple.edu January 21, 2012
Educational Opportunities at Temple University Deborah B. Nelson, Ph.D. dnelson@temple.edu January 21, 2012 Educational Opportunities at Temple University Master of Science in Clinical Research and Translational
More informationNursing Oncology Training Course
King Hussein Cancer Center Nursing Oncology Training Course Oncology Nursing Program Knowledge is the mind, Attitude is the heart and Practice is the hand KAP is the human Fax +962 5300 460 ext 2343 Page
More informationCancer Support. Services and Resources. A guide for patients of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Cancer Support Services and Resources A guide for patients of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University Support where and when you want it The people and groups listed
More informationA leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
More informationProton Therapy System A NEW WAY TO DO WHAT YOU DO BEST FIGHT CANCER
Proton Therapy System A NEW WAY TO DO WHAT YOU DO BEST FIGHT CANCER Particle Therapy is one of my top initiatives as CEO of. We are leveraging all of our existing and future technologies from image guidance,
More informationPh.D. in Molecular Medicine
Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to
More informationGraduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine
Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine Graduate Certificate in Metabolic & Nutritional Medicine Graduate Certificate Metabolic & Nutritional Medicine Purpose
More information2013 Implementation Strategy Report: UC Irvine Health; A valuable asset to Orange County
2013 Implementation Strategy Report: UC Irvine Health; A valuable asset to Orange County UC (University of California) Health is the fourth largest health system in California, and includes the UC Irvine
More informationOctober 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892
October 17, 2005 Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 Dear Dr. Zerhouni: The undersigned nonprofit medical and scientific societies
More information2014 Report of Cancer Program Activities for 2013
2014 Report of Cancer Program Activities for 2013 The University of Vermont Health Network-Central Vermont Medical Center (UVMHN-CVMC) Cancer Committee is pleased to present our Cancer Program Annual Report
More informationSpecific Standards of Accreditation for Residency Programs in General Surgery
Specific Standards of Accreditation for Residency Programs in General Surgery 2010 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation of the
More informationInvestor Presentation Q4 2015
Investor Presentation Q4 2015 Forward Looking Statement These slides and any accompanying oral presentation by Intuitive Surgical, Inc. contain estimates and forward-looking statements. Actual results
More information2014 Nursing and Allied Health Publications
2014 Nursing and Allied Health Publications Authoritative protocols and best practices Innovative information to ensure optimal patient outcomes Leading-edge data for improving care across the lifespan
More informationEpidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD
Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of
More informationAdmissions...713/500-5116 Alumni Relations...713/500-5065 Continuing Medical Education...713/500-5249 Educational Programs...
fact book The University of Texas Health Science Center at Houston in the Texas Medic I-45 59 Lyndon B. Johnson Gen Hospital I-10 I-10 Rice University Campus Downtown Houston 59 Texas Medical Center I-45
More informationDraft NIEHS Strategic Plan. Mission, Vision, Strategic Pillars, Strategic Goals. Draft Mission Statement
Draft NIEHS Strategic Plan Mission, Vision, Strategic Pillars, Strategic Goals Draft Mission Statement The mission of the National Institute of Environmental Health Sciences is to discover how the environment
More informationMANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850
LEBANON Lung Cancer Screening Program One Medical Center Drive Lebanon, NH 03756 (603) 650-4400 (866) 966-1601 Toll-free cancer.dartmouth.edu/lungscreening MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationJUMISC JUMISC. For further information visit our website:
STEM CELL THERAPY COMPANY PROFILE & SCIENTIFIC ACTIVITIES For further information visit our website: WWW.CCMIJESUSUSON.COM 20 14 JUMISC JUMISC Carretera N-521, km. 41,8 10071 CÁCERES (SPAIN) Tel. (+34)
More informationGoals and Objectives: Breast Cancer Service Department of Radiation Oncology
Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including
More informationCancer Clinical Trials: In-Depth Information
Cancer Clinical Trials: In-Depth Information The Drug Development and Approval Process 1. Early research and preclinical testing 2. IND application filed with FDA 3. Clinical trials (phases 1, 2, and 3)
More informationNews Release. Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Your Contacts News Release Merck KGaA, Darmstadt, Germany Media: Markus Talanow +49 6151 72 7144 Investor Relations +49 6151 72 3321 Pfizer Inc., New York, USA Media: Sally Beatty +1 212 733 6566 Investor
More informationLung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
More informationProton Therapy for Cancer: A New Technology Brief
September 8, 2009 Volume 6 / Number 17 A Closer Look This is the second article in a series of stories related to cancer technology. Look for the symbol on the left in an upcoming issue for the next article
More information